Intellia Therapeutics (NTLA) Current Assets (2016 - 2025)
Historic Current Assets for Intellia Therapeutics (NTLA) over the last 11 years, with Q3 2025 value amounting to $581.9 million.
- Intellia Therapeutics' Current Assets fell 1814.05% to $581.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $581.9 million, marking a year-over-year decrease of 1814.05%. This contributed to the annual value of $639.9 million for FY2024, which is 3590.67% down from last year.
- Per Intellia Therapeutics' latest filing, its Current Assets stood at $581.9 million for Q3 2025, which was down 1814.05% from $495.9 million recorded in Q2 2025.
- Over the past 5 years, Intellia Therapeutics' Current Assets peaked at $1.2 billion during Q4 2022, and registered a low of $495.9 million during Q2 2025.
- Moreover, its 5-year median value for Current Assets was $814.8 million (2021), whereas its average is $789.3 million.
- Per our database at Business Quant, Intellia Therapeutics' Current Assets skyrocketed by 12282.18% in 2021 and then crashed by 3762.84% in 2025.
- Quarter analysis of 5 years shows Intellia Therapeutics' Current Assets stood at $769.3 million in 2021, then skyrocketed by 58.17% to $1.2 billion in 2022, then dropped by 17.95% to $998.3 million in 2023, then tumbled by 35.91% to $639.9 million in 2024, then fell by 9.05% to $581.9 million in 2025.
- Its Current Assets was $581.9 million in Q3 2025, compared to $495.9 million in Q2 2025 and $551.4 million in Q1 2025.